Skip to main content
Top
Published in: Clinical Rheumatology 2/2017

01-02-2017 | Original Article

Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis

Authors: Han Cen, Hua Huang, Li-Na Zhang, Li-Ya Liu, Li Zhou, Xia-Fei Xin, Ren-Jie Zhuo

Published in: Clinical Rheumatology | Issue 2/2017

Login to get access

Abstract

The aim of our study was to conduct a meta-analysis to assess whether combined evidence shows associations between C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and genetic susceptibility to rheumatoid arthritis (RA). A total of 11 articles involving 20 comparisons were included, containing 12 comparisons for the MTHFR C677T polymorphism and 8 comparisons for the MTHFR A1298C polymorphism. Significant evidence was detected for the association of RA susceptibility with the MTHFR C677T polymorphism T allele under allelic contrast and dominant model in Asians (T versus C, OR = 1.300, 95 % CI = 1.104–1.531, p = 0.002; TT + CT versus CC, OR = 1.495, 95 % CI = 1.187–1.882, p = 0.001). Significant association between RA susceptibility and the MTHFR A1298C polymorphism A allele under recessive model was found in the overall meta-analysis (AA versus AC + CC, OR = 1.281, 95 % CI = 1.048–1.565, p = 0.016). Our meta-analysis results demonstrate that the MTHFR C677T polymorphism is involved in the genetic susceptibility of RA in Asians, and the MTHFR A1298C polymorphism is associated with genetic susceptibility to RA in the overall population. Given the paucity of studies, especially in non-Asian populations, further studies with larger sample sizes are required to elucidate the role of MTHFR polymorphisms in the genetic basis of RA in different ethnic populations.
Appendix
Available only for authorised users
Literature
2.
go back to reference Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW, Chen S, Mu R, He J, Zhao Y, Long L, Liu YY, Liu X, Lu XL, Li YH, Wang SY, Pan SS, Li C, Wang HY, Li ZG (2012) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51:721–729CrossRef Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW, Chen S, Mu R, He J, Zhao Y, Long L, Liu YY, Liu X, Lu XL, Li YH, Wang SY, Pan SS, Li C, Wang HY, Li ZG (2012) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51:721–729CrossRef
4.
go back to reference Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24:56–59PubMed Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24:56–59PubMed
6.
go back to reference Lazzerini PE, Selvi E, Lorenzini S, Capecchi PL, Ghittoni R, Bisogno S, Catenaccio M, Marcolongo R, Galeazzi M, Laghi-Pasini F (2006) Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24:387–393PubMed Lazzerini PE, Selvi E, Lorenzini S, Capecchi PL, Ghittoni R, Bisogno S, Catenaccio M, Marcolongo R, Galeazzi M, Laghi-Pasini F (2006) Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24:387–393PubMed
7.
go back to reference Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K (2009) Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 14:49–54CrossRefPubMed Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K (2009) Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 14:49–54CrossRefPubMed
8.
go back to reference Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9:652–656CrossRefPubMed Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9:652–656CrossRefPubMed
9.
go back to reference Cornélis F, Fauré S, Martinez M, Prud’homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A, Pascual-Salcedo D, Maenaut K, Westhovens R, Migliorini P, Tran TH, Delaye A, Prince N, Lefevre C, Thomas G, Poirier M, Soubigou S, Alibert O, Lasbleiz S, Fouix S, Bouchier C, Lioté F, Loste MN, Lepage V, Charron D, Gyapay G, Lopes-Vaz A, Kuntz D, Bardin T, Weissenbach J, ECRAF (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 95:10746–10750CrossRefPubMedPubMedCentral Cornélis F, Fauré S, Martinez M, Prud’homme JF, Fritz P, Dib C, Alves H, Barrera P, de Vries N, Balsa A, Pascual-Salcedo D, Maenaut K, Westhovens R, Migliorini P, Tran TH, Delaye A, Prince N, Lefevre C, Thomas G, Poirier M, Soubigou S, Alibert O, Lasbleiz S, Fouix S, Bouchier C, Lioté F, Loste MN, Lepage V, Charron D, Gyapay G, Lopes-Vaz A, Kuntz D, Bardin T, Weissenbach J, ECRAF (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 95:10746–10750CrossRefPubMedPubMedCentral
10.
go back to reference Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K, Tanaka Y, Shiozawa K, Imura S (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10:1891–1895CrossRefPubMed Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K, Tanaka Y, Shiozawa K, Imura S (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10:1891–1895CrossRefPubMed
11.
go back to reference MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S, Brown MA, Bell J, Silman A, Ollier W, Wordsworth P, Worthington J (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639CrossRefPubMed MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S, Brown MA, Bell J, Silman A, Ollier W, Wordsworth P, Worthington J (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639CrossRefPubMed
12.
go back to reference Lee, YH, Bae, SC (2015) Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis. Clin Rheumatol [Epub ahead of print] Lee, YH, Bae, SC (2015) Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis. Clin Rheumatol [Epub ahead of print]
13.
go back to reference Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414–421PubMedPubMedCentral Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414–421PubMedPubMedCentral
14.
go back to reference Rozen R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523–526PubMed Rozen R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523–526PubMed
15.
go back to reference van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–1051CrossRefPubMedPubMedCentral van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–1051CrossRefPubMedPubMedCentral
16.
go back to reference Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169–172CrossRefPubMed Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169–172CrossRefPubMed
17.
go back to reference Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656–1661PubMed Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129:1656–1661PubMed
18.
go back to reference Boughrara W, Aberkane M, Fodil M, Benzaoui A, Dorgham S, Zemani F, Dahmani C, Petit-Teixeira E, Boudjema A (2015) Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: a case-control study. Acta Reumatol Port 40:363–371PubMed Boughrara W, Aberkane M, Fodil M, Benzaoui A, Dorgham S, Zemani F, Dahmani C, Petit-Teixeira E, Boudjema A (2015) Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: a case-control study. Acta Reumatol Port 40:363–371PubMed
19.
go back to reference Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis. PLoS One 10(7):e0131960CrossRefPubMedPubMedCentral Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis. PLoS One 10(7):e0131960CrossRefPubMedPubMedCentral
20.
go back to reference Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J (2015) The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients. Rheumatol Int 35:1149–1161CrossRefPubMed Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J (2015) The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients. Rheumatol Int 35:1149–1161CrossRefPubMed
21.
go back to reference Saleh MM, Irshaid YM, Mustafa KN (2015) Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 53:154–162CrossRefPubMed Saleh MM, Irshaid YM, Mustafa KN (2015) Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 53:154–162CrossRefPubMed
22.
go back to reference Inanir A, Yigit S, Tekcan A, Tural S, Kismali G (2013) IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol Lett 152:104–108CrossRefPubMed Inanir A, Yigit S, Tekcan A, Tural S, Kismali G (2013) IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol Lett 152:104–108CrossRefPubMed
23.
go back to reference Shi YH, Zhou RH, Xu J, Zhu FX, Li BZ, Li LM, Mo HY (2013) Relationship between single nucleotide polymorphism of methylenetetrahydrofolate reductase gene and the side effect of low-dose methotrexate in the treatment of rheumatoid arthritis. Chin J New Clin Med 6:211–214 Shi YH, Zhou RH, Xu J, Zhu FX, Li BZ, Li LM, Mo HY (2013) Relationship between single nucleotide polymorphism of methylenetetrahydrofolate reductase gene and the side effect of low-dose methotrexate in the treatment of rheumatoid arthritis. Chin J New Clin Med 6:211–214
24.
go back to reference Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA (2012) Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. OMICS 16:589–595CrossRefPubMed Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA (2012) Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. OMICS 16:589–595CrossRefPubMed
25.
go back to reference Taşbaş O, Borman P, Gürhan Karabulut H, Tükün A, Yorgancıoğlu R (2011) The frequency of A1298C and C677T polymorphisms of the methylenetetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol J 5:30–35CrossRefPubMedPubMedCentral Taşbaş O, Borman P, Gürhan Karabulut H, Tükün A, Yorgancıoğlu R (2011) The frequency of A1298C and C677T polymorphisms of the methylenetetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol J 5:30–35CrossRefPubMedPubMedCentral
26.
go back to reference Xiao H, Xu JH, Zhou XM, Zhang ZH, Shen SH, Li YW (2011) Correlation of methylene tetrahydrofolate reductase gene single nucleotide polymorphisms and therapeutic effect of methotrexate in rheumatoid arthritis patients. Acta Univ Med Anhui 46:1157–1161 Xiao H, Xu JH, Zhou XM, Zhang ZH, Shen SH, Li YW (2011) Correlation of methylene tetrahydrofolate reductase gene single nucleotide polymorphisms and therapeutic effect of methotrexate in rheumatoid arthritis patients. Acta Univ Med Anhui 46:1157–1161
27.
go back to reference Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA (2010) A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 12:R71CrossRefPubMedPubMedCentral Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA (2010) A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 12:R71CrossRefPubMedPubMedCentral
28.
go back to reference Cai YM, Gong WX (2009) Linkage study on methylenetetrahydrofolate reductase single nucleotide polymorphisms and methotrexate-related adverse effects in patients with rheumatoid arthritis. Chin J Prim Med Pharm 16:1155–1157 Cai YM, Gong WX (2009) Linkage study on methylenetetrahydrofolate reductase single nucleotide polymorphisms and methotrexate-related adverse effects in patients with rheumatoid arthritis. Chin J Prim Med Pharm 16:1155–1157
29.
go back to reference Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A (2009) Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Clin Exp Rheumatol 27:499–502PubMed Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A (2009) Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Clin Exp Rheumatol 27:499–502PubMed
30.
go back to reference Rubini M, Padovan M, Baricordi O, Fotinidi M, Govoni M, Trotta F (2008) The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients. Clin Exp Rheumatol 26:163PubMed Rubini M, Padovan M, Baricordi O, Fotinidi M, Govoni M, Trotta F (2008) The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients. Clin Exp Rheumatol 26:163PubMed
31.
go back to reference Ghodke Y, Chopra A, Joshi K, Patwardhan B (2008) Are thymidylate synthase and methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients? Clin Rheumatol 27:787–789CrossRefPubMed Ghodke Y, Chopra A, Joshi K, Patwardhan B (2008) Are thymidylate synthase and methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients? Clin Rheumatol 27:787–789CrossRefPubMed
32.
go back to reference Zhou XM, Xu JH, Xu SQ (2008) Relationship between the single nucleotide polymorphism of 5,10-methylenetetrahydrofolate reductase gene and the treatment of methotrexate in rheumatoid arthritis. Chin J Rheumatol 12:598–602 Zhou XM, Xu JH, Xu SQ (2008) Relationship between the single nucleotide polymorphism of 5,10-methylenetetrahydrofolate reductase gene and the treatment of methotrexate in rheumatoid arthritis. Chin J Rheumatol 12:598–602
33.
go back to reference Xu XY, Wang MM, Xiao CS (2007) The study of the relationship of MTHFR polymorphisms with rheumatoid diseases. J Southeast Univ (Med Sci Edi) 26:38–41 Xu XY, Wang MM, Xiao CS (2007) The study of the relationship of MTHFR polymorphisms with rheumatoid diseases. J Southeast Univ (Med Sci Edi) 26:38–41
34.
go back to reference Hughes LB, Beasley TM, Patel H, Tiwari HK, Morgan SL, Baggott JE, Saag KG, McNicholl J, Moreland LW, Alarcón GS, Bridges SL Jr (2006) Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 65:1213–1218CrossRefPubMedPubMedCentral Hughes LB, Beasley TM, Patel H, Tiwari HK, Morgan SL, Baggott JE, Saag KG, McNicholl J, Moreland LW, Alarcón GS, Bridges SL Jr (2006) Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 65:1213–1218CrossRefPubMedPubMedCentral
35.
go back to reference Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63:1227–1231CrossRefPubMedPubMedCentral Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63:1227–1231CrossRefPubMedPubMedCentral
37.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedPubMedCentral
38.
go back to reference Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed
39.
41.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
42.
go back to reference Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an “anchor” drug? Autoimmun Rev 13:1102–1108CrossRefPubMed Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an “anchor” drug? Autoimmun Rev 13:1102–1108CrossRefPubMed
43.
go back to reference Song GG, Bae SC, Lee YH (2014) Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin Rheumatol 33:1715–1724CrossRefPubMed Song GG, Bae SC, Lee YH (2014) Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin Rheumatol 33:1715–1724CrossRefPubMed
44.
go back to reference Morgan MD, Al-Shaarawy N, Martin S, Robinson JI, Twigg S, YEAR Consortium, Magdy AA, Omar AS, Ghattas MH, Emery P, Barrett JH, Morgan AW (2014) MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis. Pharmacogenomics 15:467–475CrossRefPubMed Morgan MD, Al-Shaarawy N, Martin S, Robinson JI, Twigg S, YEAR Consortium, Magdy AA, Omar AS, Ghattas MH, Emery P, Barrett JH, Morgan AW (2014) MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis. Pharmacogenomics 15:467–475CrossRefPubMed
45.
go back to reference Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI (2006) Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35:112–116CrossRefPubMed Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI (2006) Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35:112–116CrossRefPubMed
46.
go back to reference Armstrong DJ, Quinn AD, McCausland EM, Finch MB, Wright GD (2007) Relationship between homocysteine and body mass index in rheumatoid arthritis. Scand J Rheumatol 36:243CrossRefPubMed Armstrong DJ, Quinn AD, McCausland EM, Finch MB, Wright GD (2007) Relationship between homocysteine and body mass index in rheumatoid arthritis. Scand J Rheumatol 36:243CrossRefPubMed
47.
go back to reference Woolf K, Manore MM (2008) Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. J Am Diet Assoc 108:443–453CrossRefPubMed Woolf K, Manore MM (2008) Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. J Am Diet Assoc 108:443–453CrossRefPubMed
48.
go back to reference Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L (2013) Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. J Rheumatol 40:809–817CrossRefPubMedPubMedCentral Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L (2013) Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. J Rheumatol 40:809–817CrossRefPubMedPubMedCentral
49.
go back to reference Brambila-Tapia AJ, Durán-González J, Sandoval-Ramírez L, Mena JP, Salazar-Páramo M, Gámez-Nava JI, González-López L, Lazalde-Medina BB, Dávalos NO, Peralta-Leal V, Vázquez del Mercado M, Beltrán-Miranda CP, Dávalos IP (2012) MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. Dis Markers 32:109–114CrossRefPubMedPubMedCentral Brambila-Tapia AJ, Durán-González J, Sandoval-Ramírez L, Mena JP, Salazar-Páramo M, Gámez-Nava JI, González-López L, Lazalde-Medina BB, Dávalos NO, Peralta-Leal V, Vázquez del Mercado M, Beltrán-Miranda CP, Dávalos IP (2012) MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. Dis Markers 32:109–114CrossRefPubMedPubMedCentral
50.
go back to reference Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Effect of MTHFR, TGFβ1, and TNFB polymorphisms on osteoporosis in rheumatoid arthritis patients. Gene 568:124–128CrossRefPubMed Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Effect of MTHFR, TGFβ1, and TNFB polymorphisms on osteoporosis in rheumatoid arthritis patients. Gene 568:124–128CrossRefPubMed
Metadata
Title
Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis
Authors
Han Cen
Hua Huang
Li-Na Zhang
Li-Ya Liu
Li Zhou
Xia-Fei Xin
Ren-Jie Zhuo
Publication date
01-02-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3348-0

Other articles of this Issue 2/2017

Clinical Rheumatology 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.